Clinical trial
Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice
NCT03199794 is registered in ClinicalTrials.gov with Baxalta now part of Shire as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice
- Lead sponsor
- Baxalta now part of Shire
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 14, 2016
- Completion date
- July 30, 2021
- Enrollment
- 50 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.
acquired hemophilia a